Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
Gögelein H
,
Brendel J
,
Steinmeyer K
,
Strübing C
,
Picard N
,
Rampe D
,
Kopp K
,
Busch AE
,
Bleich M
.
???displayArticle.abstract???
Previous studies in pigs and goats have demonstrated that AVE0118 prolongs atrial refractoriness without any effect on the QT-interval. The purpose of the present study was to investigate the effect of the compound on various cardiac ion channels. AVE0118 blocked the pig Kv1.5 and the human Kv1.5 expressed in Xenopus oocytes with IC(50) values of 5.4+/-0.7 microM and 6.2+/-0.4 microM respectively. In Chinese hamster ovary (CHO) cells, AVE0118 decreased the steady-state hKv1.5 current with an IC(50) of 1.1+/-0.2 microM. The hKv4.3/KChIP2.2 current in CHO cells was blocked by AVE0118 by accelerating the apparent time-constant of inactivation ( tau(inact)), and the integral current was inhibited with an IC(50) of 3.4+/-0.5 microM. At 10 microM AVE0118 tau(inact) decreased from 9.3+/-0.6 ms ( n=8, control) to 3.0+/-0.3 ms ( n=8). The K(ACh) current was investigated in isolated pig atrial myocytes by application of 10 microM carbachol. At a clamp potential of -100 mV the I(KACh) was half-maximally blocked by 4.5+/-1.6 microM AVE0118. In the absence of carbachol, AVE0118 had no effect on the inward current recorded at -100 mV. Effects on the I(Kr) current were investigated on HERG channels expressed in CHO cells. AVE0118 blocked this current half-maximally at approximately 10 microM. Comparable results were obtained in isolated guinea pig ventricular myocytes, where half-maximal inhibition of the I(Kr) tail current occurred at a similar concentration of AVE0118. Other ionic currents, like the I(Ks), I(KATP) (recorded in guinea pig ventricular myocytes), and L-type Ca(2+) (recorded in pig atrial myocytes) were blocked by 10 microM AVE0118 by 10+/-3% ( n=6), 28+/-7% ( n=4), and 22+/-13% ( n=5) respectively. In summary, AVE0118 preferentially inhibits the atrial K(+) channels I(Kur), I(to) and I(KACH). This profile may explain the selective prolongation of atrial refractoriness described previously in pigs and goats.
Amos,
Differences between outward currents of human atrial and subepicardial ventricular myocytes.
1996, Pubmed
Amos,
Differences between outward currents of human atrial and subepicardial ventricular myocytes.
1996,
Pubmed
An,
Modulation of A-type potassium channels by a family of calcium sensors.
2000,
Pubmed
,
Xenbase
Bachmann,
Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
2001,
Pubmed
,
Xenbase
Barry,
Myocardial potassium channels: electrophysiological and molecular diversity.
1996,
Pubmed
Blaauw,
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
2004,
Pubmed
Bosch,
Cellular electrophysiology of atrial fibrillation.
2002,
Pubmed
Decher,
hKChIP2 is a functional modifier of hKv4.3 potassium channels: cloning and expression of a short hKChIP2 splice variant.
2001,
Pubmed
,
Xenbase
Dilks,
Cloning and expression of the human kv4.3 potassium channel.
1999,
Pubmed
,
Xenbase
Dixon,
Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current.
1996,
Pubmed
Dobrev,
Remodeling of cardiomyocyte ion channels in human atrial fibrillation.
2003,
Pubmed
Dukes,
Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
1990,
Pubmed
Falk,
Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
1989,
Pubmed
Fedida,
Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current.
1993,
Pubmed
Feld,
Atrial fibrillation. Is there a safe and highly effective pharmacological treatment?
1990,
Pubmed
Feng,
Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes.
1997,
Pubmed
Gögelein,
HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells.
1998,
Pubmed
Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed
Hart,
Atrial fibrillation and stroke : concepts and controversies.
2001,
Pubmed
Kannel,
Epidemiologic features of chronic atrial fibrillation: the Framingham study.
1982,
Pubmed
Knobloch,
Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
2002,
Pubmed
Krause,
Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim.
1995,
Pubmed
Li,
Evidence for two components of delayed rectifier K+ current in human ventricular myocytes.
1996,
Pubmed
Middlekauff,
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.
1991,
Pubmed
Nagasawa,
Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter.
2002,
Pubmed
Ohya,
Molecular cloning and expression of the novel splice variants of K(+) channel-interacting protein 2.
2001,
Pubmed
Rampe,
A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
1997,
Pubmed
Seki,
Effects of NIP-141 on K currents in human atrial myocytes.
2002,
Pubmed
Singh,
Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
2000,
Pubmed
Tamkun,
Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle.
1991,
Pubmed
Torp-Pedersen,
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
1999,
Pubmed
Villmann,
Kainate binding proteins possess functional ion channel domains.
1997,
Pubmed
,
Xenbase
Waldo,
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.
1996,
Pubmed
Wang,
Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
1995,
Pubmed
Wang,
Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.
1993,
Pubmed
Wettwer,
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation.
2004,
Pubmed
Wirth,
Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
2001,
Pubmed
Wirth,
Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
2003,
Pubmed